Sicca syndrome and anti-SSA/Ro antibodies in patients with suspected or definite multiple sclerosis

Thirty-eight consecutive patients with primary Sjögren's syndrome (SS) and 36 with suspected (15 cases) or probable to definite (21 cases) multiple sclerosis (MS) underwent thorough neuropsychiatric and rheumatological examinations in order to detect either the presence of central neurologic involvement in SS or the presence of clinical and immunologic abnormalities typical of SS in MS. The only neuropsychiatric abnormality we found in patients first recorded for primary SS was major depression in 5 cases. On the other hand, one patient with suspected MS because of mild gait ataxia and right hemiparesis fulfilled the diagnostic criteria for SS. As for serologic tests, 6 out of 21 patients with probable to definite MS and 1 out of 15 with suspected MS had low-titre antinuclear antibodies. One patient with definite MS had also circulating anti-SSA/Ro antibodies, detected by gel double diffusion, but did not develop sicca symptoms after a 2-year follow-up. In the present study, the association between SS and MS was considerably weaker than that recently reported in other studies, and might be regarded as a chance finding.

Multiple sclerosis: disability and mortality in a cohort of clinically diagnosed patients

A sample of hospitalized MS patients was selected according to clinical and demographic criteria with the aim of establishing prognostic factors. The sample included 52 patients with first hospitalization from 1 January, 1975, to 31 December, 1976. At follow-up after 12 years a malignant course was observed in 33 patients (death in 13, severe disability in 20 patients). The malignant course was related to age at onset (greater than or equal to 35 years) and higher disability, progressive course and cerebellar symptoms at onset. One half of patients with a relapsing-remitting course entered into a progressive phase of the disease after a mean duration of 7.3 years.

A study of hand preference in myasthenia gravis

A recent study reported an association between left-handedness and some pathologies, such as autoimmune diseases, including myasthenia gravis (MG). We studied hand preference in 102 patients with a generalized autoimmune form of myasthenia gravis and in a control group of 178 subjects. We employed Oldfield's inventory with a few minor modifications. The questionnaire also asked the hand preference of patients' and controls' relatives. For each subject, the laterality quotient (LQ) was calculated and submitted to ANOVA. The frequency of left-handedness in controls was similar to that reported in the literature. Although left-handedness occurred less often in myasthenics, the difference between the two groups was not significant. Also the frequency of left-handedness in relatives of myasthenic patients did not differ from that observed in controls.

The Multiple Sclerosis Cooperative Etiological Study in Italy: preliminary analysis of CSF findings

295 newly diagnosed Multiple Sclerosis (MS) patients were investigated for interdependence of CSF abnormalities: leukocyte count, CSF/serum albumin ratio, CSF IgG index and intrathecal synthesis of oligoclonal IgG. Only 7% of patients had no CSF abnormality. The most frequent abnormal finding was the presence of intrathecal synthesis of oligoclonal IgG. Polyacrylamide isoelectric focusing appeared more sensitive than agarose electrophoresis for the detection of abnormal CSF fractions. CSF IgG index had low negative and high positive predictive value when compared with electrophoretic methods. Suspected MS had the lowest frequency of abnormal CSF parameters. Patients with oligoclonal CSF bands (OB+) did not differ in age, sex, disease duration or annual bout rate from patients without oligoclonal bands (OB-). CSF leukocyte count was higher in OB+ than in OB- patients. Low CSF cell count was a hallmark of progressive disease. In OB+ patients CSF cell count correlated with CSF IgG index during the first five years of disease and declined with increasing disease duration. In later disease phases CSF IgG index correlated negatively with CSF/serum albumin ratio. 5 years follow-up of this series of patients is in progress to assess the diagnostic and prognostic values of CSF abnormalities in Multiple Sclerosis.

Treatment of arterial hypertension with nifedipine in patients with chronic renal insufficiency

The acute and chronic antihypertensive effects of nifedipine were investigated in patients with chronic renal insufficiency (CRI). The acute effects were assessed after the administration either of a fast-release nifedipine capsule or a slow-release nifedipine tablet in 10 and 15 patients respectively. Both the preparations induced prompt and marked reduction of systolic and of diastolic blood pressure, but the capsules showed a shorter antihypertensive effect (2 hours) than tablets (more than 6 hours). The chronic effects of nifedipine tablets given in addition to the previous therapy was assessed in 25 patients with CRI and resistant hypertension. Both systolic and diastolic blood pressure values promptly fell and maintained within the normal range over the whole period of the study (12 months).

Cutaneous abnormalities in uremic patients

94 uremic patients, 68 on regular hemodialysis treatment (RHT) and 26 on chronic ambulatory peritoneal dialysis (CAPD), were followed for up to 20 months in search of dermatological manifestations. 79% of RHT and 76% of CAPD patients had some kind of cutaneous lesion. The most characteristic features of cutaneous involvement in RHT and CAPD patients were: cutaneous xerosis, pruritus, infectious manifestations and disorders of pigmentation. In 4 RHT patients, precancerous and cancerous manifestations were also observed.

Branched chain and aromatic free amino acids in plasma and skeletal muscle of uremic patients undergoing hemodialysis and CAPD

Plasma and skeletal muscle free amino acids were measured in patients submitted to Hemodialysis (HD) or Continuous Ambulatory Peritoneal Dialysis (CAPD) in order to evaluate the effects of these different dialysis modalities on amino acid pools; the data were compared with those obtained in control subjects and in patients with advanced Chronic Renal Failure (CRF) not submitted to Regular Dialysis Treatment (RDT). Our findings show low intracellular concentrations of VAL, total Branched Chain Amino Acid (BCAA) and TYR in uremic patients treated with CAPD but not in those undergoing HD. The observed differences in muscle amino acid pattern could be well explained by a changed amino acid metabolism regulation in CAPD, possibly related to the sustained hyperinsulinism and to an increased rate of hepatic protein synthesis.

Hemodialysis without anticoagulants: efficiency and hemostatic aspects

In 29 patients with high risk of bleeding, 111 hemodialyses have been performed without heparin (WHD) or other anticoagulants. The same patients were switched to low dose heparin dialysis (LDHD) as soon as the bleeding risk had ceased. The dialyzer had to be changed in 11 and the drip chamber in 20 WHDs because of partial clotting. This phenomenon did not occur during LDHD. The comparative efficiencies of the two techniques were evaluated by measuring the urea and creatinine clearances of the dialyzers. No significant difference between LDHD and WHD clearances was observed. In 7 of 29 patients, hemostasis variables were studied before, during and after both modes of treatment. Fibrinogen, platelet count, antithrombin III and prothrombin time did not differ with the different dialysis procedures. During dialysis, platelet factor 4 (PF4) levels were significantly higher than baseline values (P less than 0.01), with no difference between WHD and LDHD. Plasma fibrinopeptide A (FPA) levels remained normal during LDHD, but significantly increased during WHD (P less than 0.001). Our data indicate that WHD is feasible, with a low risk of extravascular coagulation. The bleeding risk is not increased during or after dialysis, and the danger of intravascular coagulation is low as confirmed by the isolated elevation of FPA plasma levels, unaccompanied by changes in other variables.

Dopamine and frusemide in oliguric acute renal failure

Into 24 oliguric patients with acute renal failure (ARF) for whom mannitol and high-dose frusemide had failed to promote a diuresis, dopamine (3 micrograms/kg/min) plus frusemide (10-15 mg/kg/h) were infused for 6-24 h. In 19 of the 24 patients this treatment produced significant increases in diuresis (from 11 +/- 7 to 85 +/- 51 ml/h; p less than 0.001) and natriuresis (from 45 +/- 13 to 88 +/- 22 mEq/1; p less than 0.001), without any significant modification of blood pressure, pulse rate or central venous pressure. 10 of the 24 patients required dialysis: 5 because therapy failed to promote diuresis and the other 5 because of their hypercatabolic state in spite of polyuria. 5 patients died of causes unrelated to ARF. Since all patients who responded were treated within 24 h after the onset of oliguria, it appears to be crucial to administer dopamine and frusemide early, before more severe anatomical and functional damage develops.

Penicillin CSF levels following intravenous therapy in syphilitic patients

Serum and CSF levels of penicillin have been determined in 13 syphilitic patients treated with relatively high doses of penicillin G by the intravenous route. Wide individual variability in the CSF/serum concentration ratio was observed. In all patients the concentration of the antibiotic in the CSF was equal to or greater than 0.03 IU/ml., which is considered to be the minimal therapeutic concentration. The potential clinical usefulness of different therapeutic regimens in the treatment of neurosyphilis is discussed.

[Visual evoked potential in multiple sclerosis]

Visual Evoked Responses (VER) by binocular flash stimulation were carried out in 30 cases of "definite" (15 cases-Group I) and of "probable" (15 cases-Group II) Multiple Sclerosis (MS). VER were recorded bilaterally by reference occiput-mastoid. Averaging of 50 responses (time base 200-500-1000 msec) was considered; measures were made by registration on X-Y Plotter. Abnormal VER by increased latencies of III and/or IV peak (Ciganek) were present uni- or bilaterally in most of the subjects (73,3% of the I Group; 66,6% of the II Group). Percentage of abnormal VER is quite higher than clinical involvement of visual pathways; it is present in 3 out of 5 patients also, in whom clinical findings were confined to spinal cord. The results are discussed with reference to the previous literature. Recording of VER seems useful in detecting involvement of visual pathways without clinical evidence.